# RESOLUTE ONYX China RCT Study

> **NCT03466151** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Medtronic Vascular** · enrollment: 550 (actual)

## Conditions studied

- Ischemic Heart Disease
- Stenotic Coronary Lesion
- Cardiovascular Diseases
- Arteriosclerosis
- Coronary Artery Disease

## Interventions

- **DEVICE:** Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
- **DEVICE:** Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System

## Key facts

- **NCT ID:** NCT03466151
- **Lead sponsor:** Medtronic Vascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-04-12
- **Primary completion:** 2021-02-12
- **Final completion:** 2026-07-31
- **Target enrollment:** 550 (ACTUAL)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03466151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03466151, "RESOLUTE ONYX China RCT Study". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03466151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*